Journal of NeuroVirology

, Volume 24, Issue 2, pp 246–253 | Cite as

Cigarette smoke and nicotine effects on brain proinflammatory responses and behavioral and motor function in HIV-1 transgenic rats

  • Walter RoyalIII
  • Adem Can
  • Todd D. Gould
  • Ming Guo
  • Jared Huse
  • Myles Jackson
  • Harry Davis
  • Joseph Bryant
Article
  • 16 Downloads

Abstract

Cognitive impairment in HIV-1 infection is associated with the induction of chronic proinflammatory responses in the brains of infected individuals. The risk of HIV-related cognitive impairment is increased by cigarette smoking, which induces brain inflammation in rodent models. To better understand the role of smoking and the associated immune response on behavioral and motor function in HIV infection, wild-type F344 and HIV-1 transgenic (HIV1Tg) rats were exposed to either smoke from nicotine-containing (regular) cigarettes, smoke from nicotine-free cigarettes, or to nicotine alone. The animals were then tested using the rotarod test (RRT), the novel object recognition test (NORT), and the open field test (OFT). Subsequently, brain frontal cortex from the rats was analyzed for levels of TNF-α, IL-1, and IL-6. On the RRT, impairment was noted for F344 rats exposed to either nicotine-free cigarette smoke or nicotine alone and for F344 and HIV1Tg rats exposed to regular cigarette smoke. Effects from the exposures on the OFT were seen only for HIV1Tg rats, for which function was worse following exposure to regular cigarette smoke as compared to exposure to nicotine alone. Expression levels for all three cytokines were overall higher for HIV1Tg than for F344 rats. For HIV1Tg rats, TNF-α, IL-1, and IL-6 gene expression levels for all exposure groups were higher than for control rats. All F344 rat exposure groups also showed significantly increased TNF-α expression levels. However, for F344 rats, IL-1 expression levels were higher only for rats exposed to nicotine-free and nicotine-containing CS, and no increase in IL-6 gene expression was noted with any of the exposures as compared to controls. These studies, therefore, demonstrate that F344 and HIV1Tg rats show differential behavioral and immune effects from these exposures. These effects may potentially reflect differences in the responsiveness of the various brain regions in the two animal species as well as the result of direct toxicity mediated by the proinflammatory cytokines that are produced by HIV proteins and by other factors that are present in regular cigarette smoke.

Keywords

HIV-1 Transgenic rat Cigarettes Smoking Cytokines Behavioral testing 

References

  1. Abbondanzo SJ, Chang SL (2014) HIV-1 transgenic rats display alterations in immunophenotype and cellular responses associated with aging. PLoS One 9:e105256CrossRefPubMedPubMedCentralGoogle Scholar
  2. Anderson E, Zink W, Xiong H, Gendelman HE (2002) HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J Acquir Immune Defic Syndr 31(Suppl 2):S43–S54CrossRefPubMedGoogle Scholar
  3. Applied Biosystems (2008) Guide to performing relative quantitation of gene expression using real-time quantitative PCR. 1–70Google Scholar
  4. Arnson Y, Shoenfeld Y, Amital H (2010) Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 34:J258–J265CrossRefPubMedGoogle Scholar
  5. Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol 61:504–513CrossRefPubMedGoogle Scholar
  6. Brack-Werner R (1999) Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 13:1–22CrossRefPubMedGoogle Scholar
  7. Brandt C, Zvolensky MJ, Woods SP, Gonzalez A, Safren SA, O'Cleirigh CM (2017) Anxiety symptoms and disorders among adults living with HIV and AIDS: a critical review and integrative synthesis of the empirical literature. Clin Psychol Rev 51:164–184CrossRefPubMedGoogle Scholar
  8. Bryant VE, Kahler CW, Devlin KN, Monti PM, Cohen RA (2013) The effects of cigarette smoking on learning and memory performance among people living with HIV/AIDS. AIDS Care 25:1308–1316CrossRefPubMedPubMedCentralGoogle Scholar
  9. Burns DM (1991) Cigarettes and cigarette smoking. Clin. Chest Med 12:631–642Google Scholar
  10. Cataldo JK, Prochaska JJ, Glantz SA (2010) Cigarette smoking is a risk factor for Alzheimer’s disease: an analysis controlling for tobacco industry affiliation. J Alzheimers Dis 19:465–480CrossRefPubMedPubMedCentralGoogle Scholar
  11. Chana G, Everall IP, Crews L, Langford D, Adame A, Grant I, Cherner M, Lazzaretto D, Heaton R, Ellis R, Masliah E (2006) Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users. Neurology 67:1486–1489CrossRefPubMedGoogle Scholar
  12. Chang L, Lim A, Lau E, Alicata D (2017) Chronic tobacco-smoking on psychopathological symptoms, impulsivity and cognitive deficits in HIV-infected individuals. J NeuroImmune Pharmacol 12:389–401CrossRefPubMedGoogle Scholar
  13. Cho YE, Lee MH, Song BJ (2017) Neuronal cell death and degeneration through increased nitroxidative stress and tau phosphorylation in HIV-1 transgenic rats. PLoS One 12:e0169945CrossRefPubMedPubMedCentralGoogle Scholar
  14. Clarke PB, Kumar R (1983) The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br J Pharmacol 78:329–337CrossRefPubMedPubMedCentralGoogle Scholar
  15. de Jonge WJ, Ulloa L (2007) The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br J Pharmacol 151:915–929CrossRefPubMedPubMedCentralGoogle Scholar
  16. Delgado-Velez M, Baez-Pagan CA, Gerena Y, Quesada O, Santiago-Perez LI, Capo-Velez CM, Wojna V, Melendez L, Leon-Rivera R, Silva W, Lasalde-Dominicci JA (2015) The alpha7-nicotinic receptor is upregulated in immune cells from HIV-seropositive women: consequences to the cholinergic anti-inflammatory response. Clin Transl Immunol 4:e53CrossRefGoogle Scholar
  17. Florek E, Marszalek A, Biczysko W, Szymanowski K (1999) The experimental investigations of the toxic influence of tobacco smoke affecting progeny during pregnancy. Hum Exp Toxicol 18:245–251CrossRefPubMedGoogle Scholar
  18. Galai N, Park LP, Wesch J, Visscher B, Riddler S, Margolick JB (1997) Effect of smoking on the clinical progression of HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 14:451–458CrossRefPubMedGoogle Scholar
  19. Geissmann F, Auffray C, Palframan R, Wirrig C, Ciocca A, Campisi L, Narni-Mancinelli E, Lauvau G (2008) Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol Cell Biol 86:398–408CrossRefPubMedGoogle Scholar
  20. Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995) Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38:755–762CrossRefPubMedGoogle Scholar
  21. Gonzalez-Lira B, Rueda-Orozco PE, Galicia O, Montes-Rodriguez CJ, Guzman K, Guevara-Martinez M, Elder JH, Prospero-Garcia O (2006) Nicotine prevents HIVgp120-caused electrophysiological and motor disturbances in rats. Neurosci Lett 394:136–139CrossRefPubMedGoogle Scholar
  22. Gorantla S, Poluektova L, Gendelman HE (2012) Rodent models for HIV-associated neurocognitive disorders. Trends Neurosci 35:197–208CrossRefPubMedPubMedCentralGoogle Scholar
  23. Harrison, JD, Dochney, JA, Blazekovic, S, Leone, F, Metzger, D, Frank, I, Gross, R, Hole, A, Mounzer, K, Siegel, S, Schnoll, RA, Ashare, RL (2017) The nature and consequences of cognitive deficits among tobacco smokers with HIV: a comparison to tobacco smokers without HIV. J Neurovirol 23:550–557Google Scholar
  24. Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I (2004) The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10:317–331CrossRefPubMedGoogle Scholar
  25. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neuro-Oncol 17:3–16Google Scholar
  26. Helleberg M, Afzal S, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Gerstoft J, Nordestgaard BG, Obel N (2013) Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis 56:727–734CrossRefPubMedGoogle Scholar
  27. Jamal A, King BA, Neff LJ, Whitmill J, Babb SD, Graffunder CM (2016) Current cigarette smoking among adults-United States, 2005-2015. MMWR Morb Mortal Wkly Rep 65:1205–1211CrossRefPubMedGoogle Scholar
  28. June HL, Tzeng Yang AR, Bryant JL, Jones O, Royal W III (2009) Vitamin A deficiency and behavioral and motor deficits in the human immunodeficiency virus type 1 transgenic rat. J Neuro-Oncol 15:380–389Google Scholar
  29. Khanna A, Guo M, Mehra M, Royal W III (2013) Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains. J Neuroimmunol 254:69–75CrossRefPubMedGoogle Scholar
  30. Kralic JE, Wheeler M, Renzi K, Ferguson C, O'Buckley TK, Grobin AC, Morrow AL, Homanics GE (2003) Deletion of GABAA receptor alpha 1 subunit-containing receptors alters responses to ethanol and other anesthetics. J Pharmacol Exp Ther 305:600–607CrossRefPubMedGoogle Scholar
  31. Lifson AR, Lando HA (2012) Smoking and HIV: prevalence, health risks, and cessation strategies. Curr HIV/AIDS Rep 9:223–230CrossRefPubMedGoogle Scholar
  32. Marks MJ, Grady SR, Collins AC (1993) Downregulation of nicotinic receptor function after chronic nicotine infusion. J Pharmacol Exp Ther 266:1268–1276PubMedGoogle Scholar
  33. Midde NM, Gomez AM, Harrod SB, Zhu J (2011) Genetically expressed HIV-1 viral proteins attenuate nicotine-induced behavioral sensitization and alter mesocorticolimbic ERK and CREB signaling in rats. Pharmacol Biochem Behav 98:587–597CrossRefPubMedPubMedCentralGoogle Scholar
  34. Moran LM, Booze RM, Mactutus CF (2013) Time and time again: temporal processing demands implicate perceptual and gating deficits in the HIV-1 transgenic rat. J NeuroImmune Pharmacol 8:988–997CrossRefPubMedPubMedCentralGoogle Scholar
  35. Nath A (2002) Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 186(Suppl 2):S193–S198CrossRefPubMedGoogle Scholar
  36. Nieman RB, Fleming J, Coker RJ, Harris JR, Mitchell DM (1993) The effect of cigarette smoking on the development of AIDS in HIV-1-seropositive individuals. AIDS 7:705–710CrossRefPubMedGoogle Scholar
  37. Reid W, Sadowska M, Denaro F, Rao S, Foulke J Jr, Hayes N, Jones O, Doodnauth D, Davis H, Sill A, O'Driscoll P, Huso D, Fouts T, Lewis G, Hill M, Kamin-Lewis R, Wei C, Ray P, Gallo RC, Reitz M, Bryant J (2001) An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A 98:9271–9276CrossRefPubMedPubMedCentralGoogle Scholar
  38. Reid WC, Casas R, Papadakis GZ, Muthusamy S, Lee DE, Ibrahim WG, Nair A, Koziol D, Maric D, Hammoud DA (2016) Neurobehavioral abnormalities in the HIV-1 transgenic rat do not correspond to neuronal hypometabolism on 18F-FDG-PET. PLoS One 11:e0152265CrossRefPubMedPubMedCentralGoogle Scholar
  39. Repunte-Canonigo V, Lefebvre C, George O, Kawamura T, Morales M, Koob GF, Califano A, Masliah E, Sanna PP (2014) Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats. Mol Neurodegener 9:26CrossRefPubMedPubMedCentralGoogle Scholar
  40. Rodriquiz RM, Wetsel WC (2006) Assessments of cognitive deficits in mutant mice. In: Levin ED, Buccafusco JJ (eds) Animal models of cognitive impairment. CRC Press, Boca Raton, pp 223–282CrossRefGoogle Scholar
  41. Royal W III, Zhang L, Guo M, Jones O, Davis H, Bryant JL (2012) Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat. J Neuroimmunol 247:16–24CrossRefPubMedPubMedCentralGoogle Scholar
  42. Shah RS, Cole JW (2010) Smoking and stroke: the more you smoke the more you stroke. Expert Rev Cardiovasc Ther 8:917–932CrossRefPubMedPubMedCentralGoogle Scholar
  43. Song G, Nesil T, Cao J, Yang Z, Chang SL, Li MD (2016) Nicotine mediates expression of genes related to antioxidant capacity and oxidative stress response in HIV-1 transgenic rat brain. J Neuro-Oncol 22:114–124Google Scholar
  44. Sopori M (2002) Effects of cigarette smoke on the immune system. Nat Rev Immunol 2:372–377CrossRefPubMedGoogle Scholar
  45. Sopori ML, Kozak W, Savage SM, Geng Y, Soszynski D, Kluger MJ, Perryman EK, Snow GE (1998) Effect of nicotine on the immune system: possible regulation of immune responses by central and peripheral mechanisms. Psychoneuroendocrinology 23:189–204CrossRefPubMedGoogle Scholar
  46. Sultana S, Li H, Puche A, Jones O, Bryant JL, Royal W (2010) Quantitation of parvalbumin+ neurons and human immunodeficiency virus type 1 (HIV-1) regulatory gene expression in the HIV-1 transgenic rat: effects of vitamin A deficiency and morphine. J Neuro-Oncol 16:33–40Google Scholar
  47. Taylor BK, Joshi C, Uppal H (2003) Stimulation of dopamine D2 receptors in the nucleus accumbens inhibits inflammatory pain. Brain Res 987:135–143CrossRefPubMedGoogle Scholar
  48. Vigorito M, Cao J, Li MD, Chang SL (2013) Acquisition and long-term retention of spatial learning in the human immunodeficiency virus-1 transgenic rat: effects of repeated nicotine treatment. J Neuro-Oncol 19:157–165Google Scholar
  49. Wojna V, Robles L, Skolasky RL, Mayo R, Selnes O, de la Torre T, Maldonado E, Nath A, Melendez LM, Lasalde-Dominicci J (2007) Associations of cigarette smoking with viral immune and cognitive function in human immunodeficiency virus-seropositive women. J Neuro-Oncol 13:561–568Google Scholar
  50. Yang Z, Nesil T, Connaghan KP, Li MD, Chang SL (2016) Modulation effect of HIV-1 viral proteins and nicotine on expression of the immune-related genes in brain of the HIV-1 transgenic rats. J NeuroImmune Pharmacol 11:562–571CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Journal of NeuroVirology, Inc. 2018

Authors and Affiliations

  • Walter RoyalIII
    • 1
    • 2
    • 3
  • Adem Can
    • 4
  • Todd D. Gould
    • 2
    • 4
    • 5
  • Ming Guo
    • 1
  • Jared Huse
    • 1
  • Myles Jackson
    • 1
  • Harry Davis
    • 6
  • Joseph Bryant
    • 6
    • 7
  1. 1.Department of NeurologyUniversity of Maryland School of MedicineBaltimoreUSA
  2. 2.Department of Anatomy and NeurobiologyUniversity of Maryland School of MedicineBaltimoreUSA
  3. 3.Baltimore Veterans Administration Medical CenterBaltimoreUSA
  4. 4.Department of PsychiatryUniversity of Maryland School of MedicineBaltimoreUSA
  5. 5.Department of PharmacologyUniversity of Maryland School of MedicineBaltimoreUSA
  6. 6.Institute of Human VirologyUniversity of Maryland School of MedicineBaltimoreUSA
  7. 7.Department of PathologyUniversity of Maryland School of MedicineBaltimoreUSA

Personalised recommendations